Pacira BioSciences Inc

NASDAQ:PCRX  
57.42
+1.14 (+2.03%)
Other Pre-Announcement

Pacira Biosciences Says Not Providing 2022 Revenue Or Gross Margin Guidance At This Time

Published: 06/14/2022 12:34 GMT
Pacira BioSciences Inc (PCRX) - Pacira Biosciences Reports Preliminary Net Product Sales for Exparel and Iovera° of $46.0 Million for May 2022.
Pacira Biosciences Inc Says Company Not Providing 2022 Revenue Or Gross Margin Guidance at This Time Given Continued Uncertainty Around Covid-19.